Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1992 Feb 15;304(6824):405–412. doi: 10.1136/bmj.304.6824.405

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.

PMCID: PMC1995577  PMID: 1445513

Abstract

To establish whether treatment with diuretic or beta blocker in hypertensive older adults reduces risk of stroke, coronary heart disease, and death.

Randomised, placebo controlled, single blind trial.

226 general practices in the MRC general practice research framework.

4396 patients aged 65-74 randomised to receive diuretic, beta blocker, or placebo. Patients had mean systolic pressures of 160-209 mm Hg and mean diastolic pressures less than 115 mm Hg during an eight week run in and were not taking antihypertensive treatment.

Patients were randomised to atenolol 50 mg daily; hydrochlorothiazide 25 mg or 50 mg plus amiloride 2.5 mg or 5 mg daily; or placebo. The regimens were adjusted to achieve specified target pressures. Mean follow up was 5.8 years.

Strokes, coronary events, and deaths from all causes.

Both treatments reduced blood pressure below the level in the placebo group. Compared with the placebo group, actively treated subjects (diuretic and beta blocker groups combined) had a 25% (95% confidence interval 3% to 42%) reduction in stroke (p = 0.04), 19% (-2% to 36%) reduction in coronary events (p = 0.08), and 17% (2% to 29%) reduction in all cardiovascular events (p = 0.03). After adjusting for baseline characteristics the diuretic group had significantly reduced risks of stroke (31% (3% to 51%) p = 0.04), coronary events (44% (21% to 60%), p = 0.0009), and all cardiovascular events (35% (17% to 49%), p = 0.0005) compared with the placebo group. The beta blocker group showed no significant reductions in these end points. The reduction in strokes was mainly in non-smokers taking the diuretic.

Hydrochlorothiazide and amiloride reduce the risk of stroke, coronary events, and all cardiovascular events in older hypertensive adults.

Full text

PDF
405

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aho K., Harmsen P., Hatano S., Marquardsen J., Smirnov V. E., Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58(1):113–130. [PMC free article] [PubMed] [Google Scholar]
  2. Amery A., Birkenhäger W., Brixko P., Bulpitt C., Clement D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1985 Jun 15;1(8442):1349–1354. doi: 10.1016/s0140-6736(85)91783-0. [DOI] [PubMed] [Google Scholar]
  3. Amery A., Hansson L., Andrén L., Gudbrandsson T., Sivertsson R., Svensson A. Hypertension in the elderly. Hypertension seminars at Ostra Hospital, Göteborg, Sweden. Acta Med Scand. 1981;210(3):221–229. [PubMed] [Google Scholar]
  4. Bird A. S., Blizard R. A., Mann A. H. Treating hypertension in the older person: an evaluation of the association of blood pressure level and its reduction with cognitive performance. J Hypertens. 1990 Feb;8(2):147–152. doi: 10.1097/00004872-199002000-00008. [DOI] [PubMed] [Google Scholar]
  5. Brown M. A., Norris R. M., Barnaby P. F., Geary G. G., Brandt P. W. Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction. Br Heart J. 1985 Oct;54(4):351–356. doi: 10.1136/hrt.54.4.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carter A. B. Hypotensive therapy in stroke survivors. Lancet. 1970 Mar 7;1(7645):485–489. doi: 10.1016/s0140-6736(70)91577-1. [DOI] [PubMed] [Google Scholar]
  7. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  8. Coope J., Warrender T. S. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed) 1986 Nov 1;293(6555):1145–1151. doi: 10.1136/bmj.293.6555.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cruickshank J. M., Thorp J. M., Zacharias F. J. Benefits and potential harm of lowering high blood pressure. Lancet. 1987 Mar 14;1(8533):581–584. doi: 10.1016/s0140-6736(87)90231-5. [DOI] [PubMed] [Google Scholar]
  10. Dahlöf B., Lindholm L. H., Hansson L., Scherstén B., Ekbom T., Wester P. O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet. 1991 Nov 23;338(8778):1281–1285. doi: 10.1016/0140-6736(91)92589-t. [DOI] [PubMed] [Google Scholar]
  11. Dollery C., Brennan P. J. The Medical Research Council Hypertension Trial: the smoking patient. Am Heart J. 1988 Jan;115(1 Pt 2):276–281. doi: 10.1016/0002-8703(88)90650-3. [DOI] [PubMed] [Google Scholar]
  12. Kannel W. B., Wolf P. A., McGee D. L., Dawber T. R., McNamara P., Castelli W. P. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA. 1981 Mar 27;245(12):1225–1229. [PubMed] [Google Scholar]
  13. Kuramoto K., Matsushita S., Kuwajima I., Murakami M. Prospective study on the treatment of mild hypertension in the aged. Jpn Heart J. 1981 Jan;22(1):75–85. doi: 10.1536/ihj.22.75. [DOI] [PubMed] [Google Scholar]
  14. Lardinois C. K., Neuman S. L. The effects of antihypertensive agents on serum lipids and lipoproteins. Arch Intern Med. 1988 Jun;148(6):1280–1288. [PubMed] [Google Scholar]
  15. Morgan T. O., Adams W. R., Hodgson M., Gibberd R. W. Failure of therapy to improve prognosis in elderly males with hypertension. Med J Aust. 1980 Jul 12;2(1):27–31. [PubMed] [Google Scholar]
  17. Pocock S. J., Hughes M. D., Lee R. J. Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med. 1987 Aug 13;317(7):426–432. doi: 10.1056/NEJM198708133170706. [DOI] [PubMed] [Google Scholar]
  18. Samuelsson O. G., Wilhelmsen L. W., Pennert K. M., Wedel H., Berglund G. L. The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden. J Hypertens. 1990 Jun;8(6):547–555. doi: 10.1097/00004872-199006000-00008. [DOI] [PubMed] [Google Scholar]
  19. Sprackling M. E., Mitchell J. R., Short A. H., Watt G. Blood pressure reduction in elderly: a randomised controlled trial of methyldopa. Br Med J (Clin Res Ed) 1981 Oct 31;283(6300):1151–1153. doi: 10.1136/bmj.283.6300.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Staessen J., Bulpitt C., Clement D., De Leeuw P., Fagard R., Fletcher A., Forette F., Leonetti G., Nissinen A., O'Malley K. Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. BMJ. 1989 Jun 10;298(6687):1552–1556. doi: 10.1136/bmj.298.6687.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wilhelmsen L., Berglund G., Elmfeldt D., Fitzsimons T., Holzgreve H., Hosie J., Hörnkvist P. E., Pennert K., Tuomilehto J., Wedel H. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens. 1987 Oct;5(5):561–572. doi: 10.1097/00004872-198710000-00009. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES